ScinoPharm Taiwan, Ltd. (TPE:1789)
Taiwan · Delayed Price · Currency is TWD 18.45
0.00 (0.00%)
Oct 23, 2025, 1:30 PM CST
ScinoPharm Taiwan Market Cap
ScinoPharm Taiwan has a market cap or net worth of 14.59 billion as of October 24, 2025. Its market cap has decreased by -27.79% in one year.
Market Cap
14.59B
Enterprise Value
12.23B
Revenue
3.19B
Ranking
n/a
PE Ratio
71.28
Stock Price
18.45
Market Cap Chart
Since October 29, 2010, ScinoPharm Taiwan's market cap has decreased from 30.44B to 14.59B, a decrease of -52.07%. That is a compound annual growth rate of -4.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 14.59B | -16.33% |
| Dec 31, 2024 | 17.44B | -16.48% |
| Dec 29, 2023 | 20.88B | 3.73% |
| Dec 30, 2022 | 20.12B | 3.25% |
| Dec 30, 2021 | 19.49B | -14.56% |
| Dec 31, 2020 | 22.81B | 8.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 252.82B |
| PharmaEssentia | 186.03B |
| Bora Pharmaceuticals Co., LTD. | 77.82B |
| Lotus Pharmaceutical | 74.82B |
| Lumosa Therapeutics | 47.00B |
| Oneness Biotech | 30.13B |
| Polaris Group | 27.85B |
| Center Laboratories | 25.76B |